Lacosamide May Trigger New Seizure Type in Children
Researchers studied the effects of a medication called lacosamide (LCM) in three young patients with epilepsy.
Pediatric epilepsy research translated for parents into normal language, including summaries about diagnosis, treatments, school, safety, and safety.
Researchers studied the effects of a medication called lacosamide (LCM) in three young patients with epilepsy.
Researchers studied infantile epilepsy spasms syndrome (IESS), a serious condition that affects about 3 in 10,000 newborns in the U.S.
Researchers studied the effectiveness of five newer anti-seizure medications (ASMs) in treating Lennox-Gastaut syndrome (LGS), a severe form of epilepsy that begins in childhood and is often resistant to treatment.
This study looked at the long-term quality of life for people who survived a severe type of epilepsy called new onset refractory status epilepticus (NORSE), including a specific form known as febrile infection-related epilepsy syndrome (FIRES).
This study looked at the blood levels of two substances, cannabidiol (CBD) and tetrahydrocannabinol (THC), in children with epilepsy that does not respond to standard treatments.
Researchers studied a specific type of epilepsy linked to mutations in the KCNT1 gene, which causes potassium channels in the brain to become overly active.
Researchers studied how to analyze data from trials that look at the effects of treatments over time, specifically focusing on a method called Latent Change Models (LCMs).
This study looked at how pyridoxine, also known as vitamin B6, might help reduce neuropsychiatric side effects caused by the epilepsy medication levetiracetam in children and adolescents.
This study looked at how effective and safe the medication lacosamide (LCM) is for children and teenagers with drug-resistant epilepsy (DRE), which means their seizures do not respond well to standard treatments.